newsfilter
← Latest News
GlobeNewswire·

Jade Biosciences to Participate in Upcoming Conferences

  • Jade Biosciences (NASDAQ: JBIO) announced participation in four upcoming conferences to host fireside chats.
  • The Guggenheim 3rd Annual Healthcare Conference fireside chat is scheduled for Tuesday, November 10, 2026, at 3:00 p.m. ET in Boston, MA.
  • The Stifel Healthcare Conference fireside chat will take place on Wednesday, November 11, 2026, at 10:00 a.m. ET in New York, NY.
  • The UBS Global Biopharma Conference fireside chat is set for Monday, November 16, 2026, at 12:00 p.m. GMT in London, UK.
  • The Jefferies Global Healthcare Conference fireside chat is scheduled for Tuesday, November 17, 2026, at 10:30 a.m. GMT in London, UK.
  • Management will host one-on-one investor meetings during these events.
  • Live webcasts of all fireside chats will be available on the Jade Biosciences website, with replays accessible for 90 days post-event.
  • The company's lead candidate JADE101 targets the cytokine APRIL for the treatment of immunoglobulin A nephropathy.
  • Jade's pipeline also includes JADE201, an afucosylated anti-BAFF-R monoclonal antibody, 101 JADE301, an anti-IFN-β monoclonal antibody.
  • Jade was launched based on assets licensed from Paragon Therapeutics, an antibody discovery engine founded by Fairmount.